Clinical Trial Logistics Market Top Players, Segments & Regional Trends By 2034

Straits Research released its highly anticipated report, “Global Clinical Trial Logistics Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 5.32 billion in 2025 and is anticipated to grow to USD 11.81 billion by 2034, growing at a CAGR of 9.30% from 2026-2034.

Market Dynamics

The clinical trial logistics market is driven by the expansion of global clinical programs that rely on coordinated distribution routes, controlled storage conditions, and structured shipment planning to support rising trial volumes across oncology, metabolic disorders, rare diseases, and advanced biological therapies. A key restraint for the market stems from the complexity of complying with varied regulatory procedures across countries, which introduces delays in customs clearance, documentation review, and temperature-controlled transport for sensitive investigational products. An opportunity emerges from the rapid development of regional depots, specialized storage hubs, and distribution centers that bring clinical materials closer to trial sites, enabling smoother site activation, faster resupply cycles, and broader participation in decentralized and hybrid study models.

Key Highlights

• Based on Service, the Transportation segment dominated the market with a share of 70.12%.
• Based on the Clinical Phase, Phase III dominated the segment with a share of 48.73%.
• Based on the Therapeutic area, the Oncology segment dominated the market with a share of 40.12%.
• Based on End-User, Bio-Pharma Manufacturers dominated the market with a share of 59.23%.
• Based on the Temperature range, the Non-Cold Chain segment is the fastest-growing with a projected rate of 10.52% during the forecast period.
• Regional Insights: North America dominated the market with 47% of market share in 2025.